X4 Prescribed drugs, Inc. (XFOR) Analyst/Investor Day Transcript
Operator
Good morning, and thanks for becoming a member of X4 Prescribed drugs Investor Day. As a reminder, this occasion is being recorded.
Earlier than we start, I wish to remind you that in as we speak’s name, we might be making sure forward-looking statements. Varied remarks that we make throughout this name concerning the firm’s future expectations, plans and prospects represent forward-looking statements. Precise outcomes could differ materially from these indicated by these forward-looking statements because of varied vital components. Please discuss with the chance components described in our most up-to-date annual report on Kind 10-Ok, quarterly report on Kind 10-Q and different SEC filings, which can be found on our web site in addition to the cautionary statements on Slide 2 of as we speak’s presentation. As well as, any forward-looking statements characterize our views as of as we speak, and shouldn’t be relied upon as representing our views as of any subsequent date. Whereas we could elect to replace these forward-looking statements sooner or later, we particularly disclaim any obligation to take action even when our views change.
Right now’s occasion is accompanied by a slide presentation, which is out there within the Occasions part of X4 Prescribed drugs’ Investor Relations web site at x4pharma.com. A replay might be out there on the web site later as we speak. [Operator Instructions]
Main our dialogue as we speak is Dr. Adam Craig, Govt Chair of X4. Beforehand, he was CEO of CTI BioPharma, the place he oversaw the approval and launch of the corporate’s first product and guided its $1.7 billion acquisition by Sobi. Dr. Craig is a doctor specializing in pediatrics and pediatric oncology, and holds a PhD in molecular oncology.
I
